2,057
Views
35
CrossRef citations to date
0
Altmetric
Extra View

Somatostatin in Alzheimer's disease: A new Role for an Old Player

, , &
Pages 1-8 | Received 02 Oct 2017, Accepted 09 Nov 2017, Published online: 31 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xing Ju, Xixia Huang, Menghua Zhang, Xianyong Lan, Dan Wang, Chen Wei & Hui Jiang. (2021) Effects of eight InDel variants in FHIT on milk traits in Xinjiang brown cattle. Animal Biotechnology 32:4, pages 486-494.
Read now

Articles from other publishers (34)

Sang Ho Kwon, Sowmya ParthibanMadhavi TippaniHeena R. DivechaNicholas J. EaglesJashandeep S. LobanaStephen R. WilliamsMichelle MakRahul A. BharadwajJoel E. KleinmanThomas M. HydeStephanie C. PageStephanie C. HicksKeri MartinowichKristen R. MaynardLeonardo Collado-Torres. (2023) Influence of Alzheimer's Disease Related Neuropathology on Local Microenvironment Gene Expression in the Human Inferior Temporal Cortex. GEN Biotechnology 2:5, pages 399-417.
Crossref
Carlos Gutierrez-Merino. (2023) Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers–Protein Interactions. International Journal of Molecular Sciences 24:18, pages 13846.
Crossref
Jeasang Yoo, Jiyeon Han & Mi Hee Lim. (2023) Transition metal ions and neurotransmitters: coordination chemistry and implications for neurodegeneration. RSC Chemical Biology 4:8, pages 548-563.
Crossref
Hyeji Jung, Seungjoon Kim, Jaewon Ko & Ji Won Um. (2023) Intracellular signaling mechanisms that shape postsynaptic GABAergic synapses. Current Opinion in Neurobiology 81, pages 102728.
Crossref
Bhushan D. Khairnar, Anjali Jha & Jyutika M. Rajwade. (2023) Rationally designed cyclic peptides and nanomaterials as ‘next-generation’ anti-amyloid therapeutics. Journal of Materials Science 58:24, pages 9834-9860.
Crossref
Frank Mazza, Alexandre Guet-McCreight, Taufik A. Valiante, John D. Griffiths & Etay Hay. (2023) In-silico EEG biomarkers of reduced inhibition in human cortical microcircuits in depression. PLOS Computational Biology 19:4, pages e1010986.
Crossref
Ahmed Hamarsha, Kumarendran Balachandran, Ahmad Tarmidi Sailan & Nurrul Shaqinah Nasruddin. (2023) Predicting Key Genes and Therapeutic Molecular Modelling to Explain the Association between Porphyromonas gingivalis (P. gingivalis) and Alzheimer’s Disease (AD). International Journal of Molecular Sciences 24:6, pages 5432.
Crossref
Declan Williams, Bei Qi Yan, Hansen Wang, Logine Negm, Christopher Sackmann, Claire Verkuyl, Vanessa Rezai-Stevens, Shehab Eid, Nimit Vediya, Christine Sato, Joel C. Watts, Holger Wille & Gerold Schmitt-Ulms. (2023) Somatostatin slows Aβ plaque deposition in aged APPNL-F/NL-F mice by blocking Aβ aggregation. Scientific Reports 13:1.
Crossref
Alexander H. Peden & Marcelo A. Barria. 2023. Prions and Diseases. Prions and Diseases 213 237 .
Lisa Neums, Devin C. Koestler, Qing Xia, Jinxiang Hu, Shachi Patel, Shelby Bell-Glenn, Dong Pei, Bo Zhang, Samuel Boyd, Prabhakar Chalise & Jeffrey A. Thompson. (2022) Assessing equivalent and inverse change in genes between diverse experiments. Frontiers in Bioinformatics 2.
Crossref
Jiyeon Han, Jiwon Yoon, Jeongcheol Shin, Eunju Nam, Tongrui Qian, Yulong Li, Kiyoung Park, Seung-Hee Lee & Mi Hee Lim. (2022) Conformational and functional changes of the native neuropeptide somatostatin occur in the presence of copper and amyloid-β. Nature Chemistry 14:9, pages 1021-1030.
Crossref
Micaela E. Consens, Yuxiao Chen, Vilas Menon, Yanling Wang, Julie A. Schneider, Philip L. De Jager, David A. Bennett, Shreejoy J. Tripathy & Daniel Felsky. (2022) Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer’s Disease. Frontiers in Molecular Neuroscience 15.
Crossref
Toshifumi Tomoda, Akiko Sumitomo, Dwight Newton & Etienne Sibille. (2022) Molecular origin of somatostatin-positive neuron vulnerability. Molecular Psychiatry 27:4, pages 2304-2314.
Crossref
Shouneng Peng, Lu Zeng, Jean-Vianney Haure-Mirande, Minghui Wang, Derek M. Huffman, Vahram Haroutunian, Michelle E. Ehrlich, Bin Zhang & Zhidong Tu. (2021) Transcriptomic Changes Highly Similar to Alzheimer’s Disease Are Observed in a Subpopulation of Individuals During Normal Brain Aging. Frontiers in Aging Neuroscience 13.
Crossref
Xiao-Lan Wang & Lianjian Li. (2021) Cell type-specific potential pathogenic genes and functional pathways in Alzheimer’s Disease. BMC Neurology 21:1.
Crossref
Vijay Kumar, Nabodita Sinha & Ashwani Kumar Thakur. (2021) Necessity of regulatory guidelines for the development of amyloid based biomaterials. Biomaterials Science 9:12, pages 4410-4422.
Crossref
Wuhan Yu, Weihua Yu, Yan Yang & Yang Lü. (2021) Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis. Frontiers in Aging Neuroscience 13.
Crossref
Hannah M.O. ReidNathan Chen-MackTaylor SnowdenBrian R. Christie. (2021) Understanding Changes in Hippocampal Interneurons Subtypes in the Pathogenesis of Alzheimer's Disease: A Systematic Review. Brain Connectivity 11:3, pages 159-179.
Crossref
Min Wu, Lyudmyla Dorosh, Gerold Schmitt-Ulms, Holger Wille & Maria Stepanova. (2021) Aggregation of Aβ40/42 chains in the presence of cyclic neuropeptides investigated by molecular dynamics simulations. PLOS Computational Biology 17:3, pages e1008771.
Crossref
Boris Guennewig, Julia Lim, Lee Marshall, Andrew N. McCorkindale, Patrick J. Paasila, Ellis Patrick, Jillian J. Kril, Glenda M. Halliday, Antony A. Cooper & Greg T. Sutherland. (2021) Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology. Scientific Reports 11:1.
Crossref
Harald Hampel, Andrea Vergallo, Filippo Caraci, A. Claudio Cuello, Pablo Lemercier, Bruno Vellas, Kelly Virecoulon Giudici, Filippo Baldacci, Britta Hänisch, Marion Haberkamp, Karl Broich, Robert Nisticò, Enzo Emanuele, Francisco Llavero, José L. Zugaza, Alejandro Lucía, Ezio Giacobini & Simone Lista. (2021) Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery. Neuropharmacology 185, pages 108081.
Crossref
Juan Jose Fernandez-Valenzuela, Raquel Sanchez-Varo, Clara Muñoz-Castro, Vanessa De Castro, Elisabeth Sanchez-Mejias, Victoria Navarro, Sebastian Jimenez, Cristina Nuñez-Diaz, Angela Gomez-Arboledas, Ines Moreno-Gonzalez, Marisa Vizuete, Jose Carlos Davila, Javier Vitorica & Antonia Gutierrez. (2020) Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer’s disease model. Scientific Reports 10:1.
Crossref
Min Zhu, Longfei Jia, Fangyu Li & Jianping Jia. (2020) Identification of KIAA0513 and Other Hub Genes Associated With Alzheimer Disease Using Weighted Gene Coexpression Network Analysis. Frontiers in Genetics 11.
Crossref
Rachel Waller, Memory Mandeya, Edward Viney, Julie E. Simpson & Stephen B. Wharton. (2020) Histological characterization of interneurons in Alzheimer's disease reveals a loss of somatostatin interneurons in the temporal cortex. Neuropathology 40:4, pages 336-346.
Crossref
Yilan Xu, Manna Zhao, Yuying Han & Heng Zhang. (2020) GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment. Frontiers in Neuroscience 14.
Crossref
Anqi Shi, Alexandra L Petrache, Jiachen Shi & Afia B Ali. (2020) Preserved Calretinin Interneurons in an App Model of Alzheimer’s Disease Disrupt Hippocampal Inhibition via Upregulated P2Y1 Purinoreceptors. Cerebral Cortex 30:3, pages 1272-1290.
Crossref
Elisabeth Sanchez‐Mejias, Cristina Nuñez‐Diaz, Raquel Sanchez‐Varo, Angela Gomez‐Arboledas, Juan Antonio Garcia‐Leon, Juan Jose Fernandez‐Valenzuela, Marina Mejias‐Ortega, Laura Trujillo‐Estrada, David Baglietto‐Vargas, Ines Moreno‐Gonzalez, Jose Carlos Davila, Javier Vitorica & Antonia Gutierrez. (2019) Distinct disease‐sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients. Brain Pathology 30:2, pages 345-363.
Crossref
Daniel Saiz-Sanchez, Isabel Ubeda-Bañon, Alicia Flores-Cuadrado, Melania Gonzalez-Rodriguez, Sandra Villar-Conde, Veronica Astillero-Lopez & Alino Martinez-Marcos. (2020) Somatostatin, Olfaction, and Neurodegeneration. Frontiers in Neuroscience 14.
Crossref
Eugene Gonzalez‐Lopez & Kent E. Vrana. (2019) Dopamine beta‐hydroxylase and its genetic variants in human health and disease. Journal of Neurochemistry 152:2, pages 157-181.
Crossref
Utpala Nanda Chowdhury, M. Babul Islam, Shamim Ahmad & Mohammad Ali Moni. (2020) Systems biology and bioinformatics approach to identify gene signatures, pathways and therapeutic targets of Alzheimer's disease. Informatics in Medicine Unlocked 21, pages 100439.
Crossref
Carla Petrella, Maria Grazia Di Certo, Christian Barbato, Francesca Gabanella, Massimo Ralli, Antonio Greco, Roberta Possenti & Cinzia Severini. (2019) Neuropeptides in Alzheimer’s Disease: An Update. Current Alzheimer Research 16:6, pages 544-558.
Crossref
Michael Solarski, Declan Williams, Mohadeseh Mehrabian, Hansen Wang, Holger Wille & Gerold Schmitt-Ulms. (2019) The human brain somatostatin interactome: SST binds selectively to P-type family ATPases. PLOS ONE 14:5, pages e0217392.
Crossref
Lavida R. K. Brooks & George I. Mias. (2019) Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimer's Disease. Frontiers in Neuroscience 13.
Crossref
S. Imindu Liyanage & Donald F. Weaver. 2019. Protein Misfolding. Protein Misfolding 371 411 .